Dec 16, 2023A new treatise on knee osteoarthritis has been published.curcuRouge® has succeeded in proofing a potential for treating human knee osteoarthritis, particularly at an early stage.
Jun 12, 2023Therabiopharma on stage at Kento Innovation Park Talk SessionOur CEO, Mr. Hashimoto, and Professor Kakeya from the Graduate School of Pharmaceutical Sciences at Kyoto University, who is also our...
Sep 3, 2021A new treatise has been published.(Updated)Title Newly Developed Highly Bioavailable Curcumin Formulation, curcuRouge™, Reduces Neutrophil/Lymphocyte Ratio in the Elderly: A...
Jul 27, 2021Kyoto University Life Science Showcase 2020, San DiegoTherabiopharma is part of the Kyoto University Life Science Showcase 2020, San Diego This event will introduce biotech startups with...
Jul 26, 2021Therabiopharma exhibited at Supply Side West 2019Therabiopharma CEO held a presentation at NCN (Nutrition Capital Network) showcasing the latest innovations on nutraceuticals and...
Jul 26, 2021Press Release: CMG and Oxaliplatin studies for colon cancerTherabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong...